Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Michael J DuffyJohn Crown

Abstract

Biomarkers are the key to personalized treatment in patients with breast cancer. While tissue biomarkers are most useful in determining prognosis and upfront predicting response to therapy, circulating protein biomarkers such as CA 15-3 and carcinoembryonic antigen are mainly used in monitoring response to endocrine or chemotherapy in patients with advanced disease. Although several centers measure biomarkers in asymptomatic patients following curative surgery for primary breast cancer, the clinical utility of this practice is unclear. Promising new biomarkers for breast cancer include circulating tumor DNA and circulating tumor cells. In contrast to circulating protein biomarkers, measurement of circulating tumor DNA-based biomarkers is potentially useful in identifying mechanisms of resistance to ongoing therapies as well as identifying new targets for further treatment. To increase clinical utility, both the established and emerging circulating biomarkers should where possible be incorporated into randomized trials evaluating new therapies in patients with breast cancer.

References

Apr 22, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J F RobertsonR W Blamey
Apr 22, 2000·Cancer Treatment Reviews·K L CheungJ F Robertson
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R C BastUNKNOWN American Society of Clinical Oncology Tumor Markers Expert Panel
Oct 30, 2001·Scandinavian Journal of Clinical and Laboratory Investigation·J SjöströmC Blomqvist
Jun 5, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R KokkoM Hakama
Oct 8, 2003·BMC Cancer·Alvaro FigueredoUNKNOWN Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care
Feb 14, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G SölétormosP Dombernowsky
Aug 20, 2004·The New England Journal of Medicine·Massimo CristofanilliDaniel F Hayes
Dec 18, 2004·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Junichi KurebayashiTetsuya Taguchi
Mar 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo CristofanilliLeon W M M Terstappen
Oct 29, 2005·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rafael MolinaPetra Stieber
Jan 18, 2006·Clinical Chemistry·Michael J Duffy
May 4, 2006·Breast Cancer Research and Treatment·Marco TampelliniLuigi Dogliotti
Oct 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gershon Y LockerUNKNOWN ASCO
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sabine RiethdorfKlaus Pantel
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingJohn Z Ayanian
Sep 18, 2007·Diseases of the Colon and Rectum·Joe J Tjandra, Miranda K Y Chan
Oct 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lyndsay HarrisUNKNOWN American Society of Clinical Oncology
Mar 31, 2009·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Luigi MarianiMassimo Gion
Oct 5, 2010·Lancet·Gordon J S RustinUNKNOWN EORTC 55955 investigators
May 10, 2011·Cancer Treatment Reviews·Chantal TséPierre-Jean Lamy
Jun 4, 2011·Cellular and Molecular Life Sciences : CMLS·Arun Satelli, Shulin Li
Jun 9, 2012·The Lancet Oncology·Anthony LucciSavitri Krishnamurthy
Mar 15, 2013·The New England Journal of Medicine·Sarah-Jane DawsonNitzan Rosenfeld
Jul 16, 2013·International Journal of Cancer. Journal International Du Cancer·M J DuffyC Sturgeon
Oct 1, 2013·The Breast : Official Journal of the European Society of Mastology·Ian E Smith, Gaia Schiavon
Oct 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R LabiancaUNKNOWN ESMO Guidelines Working Group
Nov 5, 2013·Nature Genetics·Weiyi ToySarat Chandarlapaty
Jan 15, 2014·International Journal of Cancer. Journal International Du Cancer·Annelieke E C A B WillemsenCarla M L van Herpen
Mar 15, 2014·Journal of the National Cancer Institute·N Lynn HenryJulie R Gralow
Jun 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey B SmerageDaniel F Hayes
Sep 24, 2014·The Breast : Official Journal of the European Society of Mastology·F CardosoE Winer

❮ Previous
Next ❯

Citations

May 5, 2020·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mariana Cartaxo AlvesAuro Del Giglio
Jun 21, 2019·Scientific Reports·Irina PetrovaAlyona Sukhanova
Mar 20, 2019·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Anastasios KyriazoglouMeletios Athanasios Dimopoulos
Oct 1, 2020·Cancers·Jiawei LiDong-Xu Liu
Oct 5, 2020·Molecular Oncology·Ulf Landegren, Maria Hammond
Feb 8, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F Ayala de la PeñaÁ González-Hernández
Oct 15, 2020·Scientific Reports·Ieva KeraiteNicholas R Leslie
Mar 6, 2021·Chemical Reviews·Lingling WuWeihong Tan
Mar 4, 2021·Clinical & Experimental Metastasis·Moa LindgrenHanna Nyström
May 1, 2021·International Journal of Molecular Sciences·Severa BundaGelareh Zadeh
May 15, 2021·Drug Delivery and Translational Research·Fahima Danesh PouyaMohadeseh Nemati

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01619111
NCT01975142

Software Mentioned

CellSearch

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.